HBM Healthcare Investments AG

Equities

HBMN

CH0012627250

Investment Management & Fund Operators

Market Closed - Swiss Exchange Other stock markets 11:31:57 2024-04-25 am EDT			5-day change	1st Jan Change
188 ^CHF	-0.42%		+1.51%	+2.96%

Apr. 03	HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	MT
Jan. 22	HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

HBM Healthcare Investments : Key Figures 31.01.2021

February 01, 2021 at 11:49 am EST

EQS Group-Ad-hoc: HBM Healthcare Investments AG / Key word(s): Monthly Figures
Key Figures 31.01.2021

01-Feb-2021 / 17:46 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 KR
The issuer is solely responsible for the content of this announcement.

	in CHF	Performance in %
	31.01.2021	MTD	FYTD	CYTD
NAV	CHF 292.14	-0.4	44.0	-0.4
Share Price	CHF 303.50	-0.5	63.8	-0.5
Total Net Assets (in million)	2'032

MTD Month to Date
FYTD Financial Year to Date (since 1.4.2020)
CYTD Calendar Year to Date (since 1.1.2021)

End of ad hoc announcement

Language:	English
Company:	HBM Healthcare Investments AG
	Bundesplatz 1
	6300 Zug
	Switzerland
Phone:	+41438887171
Fax:	+41438887172
E-mail:	info@hbmhealthcare.com
Internet:	https://www.hbmhealthcare.com
ISIN:	CH0012627250
Valor:	1262725
Listed:	SIX Swiss Exchange
EQS News ID:	1164962


End of Announcement	EQS Group News Service

1164962 01-Feb-2021 CET/CEST

Latest news about HBM Healthcare Investments AG

HBM Healthcare Investments Warns of CHF1 Million Loss for FY24	Apr. 03	MT
HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Jan. 22	CI
HBM Healthcare Investments Logs Lower Fiscal Q3 Loss	Jan. 22	MT
HBM Healthcare Investments Warns of FY24 Nine-month Net Loss	Jan. 04	MT
AbbVie to Buy Cancer-focused ImmunoGen for $10.1 Billion	Nov. 30	MT
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	Nov. 21	MT
HBM Healthcare Investments Launches Share Buyback	23-10-16	MT
HBM Healthcare Investments AG Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	23-10-16	CI
HBM Healthcare Investments Logs Higher Fiscal H1 Loss	23-10-16	MT
Tranche Update on HBM Healthcare Investments AG's Equity Buyback Plan announced on July 5, 2023.	23-10-16	CI
HBM Healthcare Investments Flags Fiscal H1 Loss	23-10-03	MT
HBM Healthcare Investments AG Reports Earnings Results for the First Quarter Ended June 30, 2023	23-07-21	CI
HBM Healthcare Investments' Ficsal Q1 NAV Per Share Declines	23-07-21	MT
HBM Healthcare Investments AG commences an Equity Buyback Plan under the authorization approved on June 10, 2022.	23-07-05	CI
HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion	23-06-26	MT
Kepler Cheuvreux Lowers Price Target on HBM Healthcare Investments, Maintains Buy Recommendation	23-06-14	MT
HBM Healthcare Investments AG Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-26	CI
HBM Healthcare Investments' Loss Widens in FY23	23-05-12	MT
HBM Healthcare Investments Posts 3% Drop in April NAV	23-05-02	MT
HBM Healthcare Invests $12 Million into US-based ArriVent Biopharma	23-03-28	MT
HBM Healthcare Investments CEO Set to Resume Duties After Health Issues	23-03-28	MT
HBM Healthcare Investments' Portfolio Company Mineralys Therapeutics Completes $192 Million IPO	23-02-13	MT
HBM Healthcare Investments CEO Takes Temporary Leave of Absence	23-01-30	MT
Nicox: HBM Healthcare Investments falls below 5% threshold	23-01-23	CF
HBM Healthcare Investments AG Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-20	CI

Chart HBM Healthcare Investments AG

Duration

Period

More charts

Company Profile

HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.

Sector

Investment Management & Fund Operators

Calendar

2024-05-07 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for HBM Healthcare Investments AG

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

188.8 CHF

Average target price

236 CHF

Spread / Average Target

+25.00%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Venture Capital

	1st Jan change	Capi.
HBM HEALTHCARE INVESTMENTS AG	+2.96%	1.43B
UMBRA COMPANIES INC.	+31.41%	12.02B
HERCULES CAPITAL, INC.	+13.47%	3.04B
OCTOPUS TITAN VCT PLC	-8.46%	1.22B
CION INVESTMENT CORPORATION	+0.71%	616M
VERUSA HOLDING	+33.12%	583M
MOLTEN VENTURES PLC	-14.45%	546M
WOORI TECHNOLOGY INVESTMENT CO., LTD	+35.09%	507M
OCTOPUS APOLLO VCT PLC	-4.17%	491M
BRITISH SMALLER COMPANIES VCT PLC	+3.90%	304M

Venture Capital